about
Markers of small cell lung cancerEpigenetics in non-small cell lung cancer: from basics to therapeuticsApoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategiesTargeting caspases in cancer therapeuticsLung cancer: a classic example of tumor escape and progression while providing opportunities for immunological interventionOld, new and emerging functions of caspases.The Janus Face of Death Receptor Signaling during Tumor ImmunoeditingMathematical modelling of cell-fate decision in response to death receptor engagementEfficient elimination of cancer cells by deoxyglucose-ABT-263/737 combination therapyFenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma.A new caspase-8 isoform caspase-8s increased sensitivity to apoptosis in Jurkat cellsX-linked ectodermal dysplasia receptor is downregulated in breast cancer via promoter methylation.Molecular cloning and characterization of murine caspase-12 gene promoter.Analysis of death receptor 5 and caspase-8 expression in primary and metastatic head and neck squamous cell carcinoma and their prognostic impactLung cancer cell lines: Useless artifacts or invaluable tools for medical science?Apoptosis and lung cancer: a review.Epigenetic silencing of apoptosis-inducing gene expression can be efficiently overcome by combined SAHA and TRAIL treatment in uterine sarcoma cellsCellular FLICE-inhibitory protein: an attractive therapeutic target?Typical bronchial carcinoid metastasizing to the brain: a case presentation.Tyrosine Phosphorylation of Caspase-8 Abrogates Its Apoptotic Activity and Promotes Activation of c-SrcBH3-only proteins in cell death initiation, malignant disease and anticancer therapy.The enigmatic roles of caspases in tumor developmentFrom procaspase-8 to caspase-8: revisiting structural functions of caspase-8.Caspase-8 as a therapeutic target in cancer.The molecular pathogenesis and management of bronchial carcinoids.DNA methylation and apoptosis resistance in cancer cellsThe human caspase-8 promoter sustains basal activity through SP1 and ETS-like transcription factors and can be up-regulated by a p53-dependent mechanism.Novel Approaches to Apoptosis-Inducing Therapies.Epigenetic mechanisms underlying arsenic-associated lung carcinogenesis.Prognostic and therapeutic relevance of FLIP and procaspase-8 overexpression in non-small cell lung cancer.Doxorubicin and etoposide sensitize small cell lung carcinoma cells expressing caspase-8 to TRAIL.Detailed analysis of expression and promoter methylation status of apoptosis-related genes in prostate cancer.Molecular mechanism of Mitomycin C-dependent caspase-8 regulation: implications for apoptosis and synergism with interferon-alpha signalling.Potentiation of neuroblastoma metastasis by loss of caspase-8.Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors.Increased expression of Apaf-1 and procaspase-3 and the functionality of intrinsic apoptosis apparatus in non-small cell lung carcinoma.Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.Retinoic acid induces caspase-8 transcription via phospho-CREB and increases apoptotic responses to death stimuli in neuroblastoma cells.Chemotherapy-induced apoptosis of S-type neuroblastoma cells requires caspase-9 and is augmented by CD95/Fas stimulation.Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival.
P2860
Q24798523-16FA73CA-B694-4919-86B4-22F284D02A3BQ26749113-117B48C3-C078-44E8-AD21-5E89B5C7EEEBQ26750639-A7742CAB-E8B3-417F-A73A-0F76B37A0F28Q26821986-5AC2D83B-BF30-449E-9CDF-DDE1D2066540Q26850218-5529525D-5CAD-4CED-902A-0750197DDAB1Q27686885-D30768E6-6880-4436-82E1-01D99ADCC694Q28070036-44AB680C-0A54-4F8D-941E-A9751B27450FQ28473094-C3A8E12D-D667-45EE-B56A-63E07FC85877Q28477131-BCD8F985-1B2F-4498-98BD-492033EEE005Q33424045-B44C1F1B-7ED1-49FC-B3EE-445BBB732A34Q33635105-B8B6F458-1322-4728-9D01-6852C40EBAD1Q33658266-0041A803-140F-44CB-9676-A1D18F05533AQ33831205-0AC970F2-FE9A-41D5-B6CC-2581D6BD1CADQ34068822-53A20227-4231-4A3E-891A-CDD0F752DD24Q35033316-4FC5CCBD-9831-4486-919A-DAD90BD19C58Q35077696-C6DBDBDD-E796-485E-9CD3-AA6ACFF947E2Q35117949-B8620405-FFC0-4FF9-A434-26B38BC99422Q35186676-75E44918-0152-4277-82F7-7F8E6E108AC2Q35710713-EE11983D-DABA-4763-B8A9-DE45E584FE54Q35996145-86DCC932-A748-4959-A38C-430EF0176376Q36463059-80A6008F-5C49-40F1-8E03-BAFDA1999975Q37342739-12BE2B3B-2B2C-40B2-BEEF-3406A6359723Q37766804-09FE1F14-1FB7-448D-9961-7F8199EDE054Q37785346-C45CCB8F-2F97-4E23-8BE7-63F0B1D7F97FQ37833109-D29D61BB-DA26-4216-BA39-22AFDB7E1515Q38202821-9C5DAE04-1A5E-4F04-9C32-4232645014A1Q38354640-AA7A72DA-2F9A-4E88-A481-BECAFED65C31Q38936710-81F85895-A4F4-4733-8793-5ECD3E197F55Q38958679-142DA817-E81C-433F-BEFF-30E2F62F1CB8Q39047967-7EF837D6-A747-4306-9C51-B7570B6EEEC3Q39711397-92627CB1-C013-4226-A5D4-3F3DD1D4CC1FQ39873806-36F14527-CB68-444C-91EA-AC9CF9EEEBE8Q40070723-122A012A-A9C1-4F98-972D-B81C94088AE0Q40332962-808C870A-13CC-42D0-886A-4F38F2648E29Q40484560-3F938FAD-84F1-47B5-AC19-30C880881FFEQ40564217-3A27FFA1-657C-454B-B6F4-561DD460E700Q40595717-C82E5CEA-BA36-442D-B970-91355FB31769Q40610235-8899104E-71E3-4EA1-AB22-041B315DBEA6Q40616422-07BBFD4C-88FE-435D-9014-8900701F879AQ41903427-E09807EF-7290-4CB9-9421-FB8678287D0D
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Differential inactivation of caspase-8 in lung cancers.
@en
type
label
Differential inactivation of caspase-8 in lung cancers.
@en
prefLabel
Differential inactivation of caspase-8 in lung cancers.
@en
P2093
P356
P1476
Differential inactivation of caspase-8 in lung cancers
@en
P2093
Adi F Gazdar
Chun Xian Huang
Elizabeth Brambilla
H Thomas Cunningham
John D Minna
Jyotsna L Reddy
Michael T Eby
Narayan Shivapurkar
Preet M Chaudhary
Shinichi Toyooka
P356
10.4161/CBT.1.1.45
P577
2002-01-01T00:00:00Z